150,000 Shares in Agilent Technologies, Inc. $A Acquired by Pacific Heights Asset Management LLC

Pacific Heights Asset Management LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 150,000 shares of the medical research company’s stock, valued at approximately $19,924,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies during the fourth quarter worth approximately $26,000. SHP Wealth Management acquired a new stake in Agilent Technologies in the 4th quarter valued at $26,000. Navalign LLC acquired a new stake in Agilent Technologies in the 4th quarter valued at $27,000. Cedar Mountain Advisors LLC bought a new stake in Agilent Technologies during the 1st quarter valued at $27,000. Finally, MV Capital Management Inc. bought a new stake in Agilent Technologies during the 4th quarter valued at $28,000.

Analysts Set New Price Targets

A number of research firms have weighed in on A. Bank of America raised their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday. Royal Bank Of Canada upped their target price on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a report on Thursday. Morgan Stanley raised their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Barclays boosted their price objective on Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
• Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
• Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.

Agilent Technologies Stock Up 1.6%

A opened at $157.60 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company’s 50-day moving average is $139.76 and its 200 day moving average is $126.85. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75. The firm has a market capitalization of $44.51 billion, a P/E ratio of 31.02, a PEG ratio of 2.74 and a beta of 1.25.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.84%. The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.